Chemical peels show promise for acne and dark spots in new study
NCT ID NCT07240051
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested three types of chemical peels—50% glycolic acid, 30% salicylic acid, and modified Jessner's—on 90 adults with mild to moderate facial acne and post-acne dark spots. Participants received one type of peel, and doctors measured improvements in acne severity and pigmentation. The goal was to see which peel works best and is safest for treating both active breakouts and leftover marks.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- chemical peels (50% glycolic acid, 30% salicylic acid, modified Jessner's solution)
- What this could lead to
- If effective, these peels could offer a safe, affordable option to reduce acne and dark spots without long-term medication.
- What could go wrong
- This is a small, completed trial with no blinding or long-term follow-up. Results may not apply to all skin types or severe acne. Risks include irritation, redness, and scarring.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACNE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cairo University
Cairo, 13114, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a vaccine clear up severe teen acne?
- A new serum aims to clear acne and boost skin confidence
- Can coconut oil calm acne without irritating sensitive skin?
- Acne fighters: ubiquinol and pomegranate peel extract put to the test
- Gut bacteria cocktail could clear acne without pills or creams
- New laser shows promise for wrinkle reduction in clinical trial